Last 12 months
Inside the activity.
0 purchase rows · 12 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 23, 2021 Filed Dec 27, 2021 21:32 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
Exercise / conversionOrdinary Shares | 30,000 | $69.72 | $2,091,600.00 |
DisclosureSEC source: 0001209191-21-071260 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: 12,340 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,240 on May 31, 2022; 2,780 on May 31, 2023; 2,452 on June 3, 2024; 1,719 on June 3, 2024; 432 on October 1, 2024; 573 on June 2, 2025 and 144 on October 1, 2025. Read SEC document |
| December 02, 2021 Filed Apr 28, 2022 17:01 UTC |
Xilas AndrewSVP and GM, Dental
|
Exercise / conversionRestricted Stock Units · Derivative | 333 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-026029 · doc4.xml · derivative · entry 3 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,380 Underlying: Ordinary Shares · 333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The STERIS RSUs will vest as follows: 606 on October 7, 2022; 503 on October 10, 2022; 333 on December 2, 2022; 605 on October 7, 2023 and 333 on December 2, 2023. F3 · derivative.exercise_date: The STERIS RSUs will vest as follows: 606 on October 7, 2022; 503 on October 10, 2022; 333 on December 2, 2022; 605 on October 7, 2023 and 333 on December 2, 2023. F3 · derivative.expiration_date: The STERIS RSUs will vest as follows: 606 on October 7, 2022; 503 on October 10, 2022; 333 on December 2, 2022; 605 on October 7, 2023 and 333 on December 2, 2023. Read SEC document |
| December 02, 2021 Filed Apr 28, 2022 17:01 UTC |
Xilas AndrewSVP and GM, Dental
|
Tax withholdingOrdinary Shares | 126 | $220.63 | $27,799.38 |
DisclosureSEC source: 0001209191-22-026029 · doc4.xml · nonDerivative · entry 2 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,380 F2 · shares: Ordinary shares withheld to satisfy taxes. F1 · balance_after: 1,156 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 289 on October 3, 2022; 289 on October 2, 2023; 289 on October 1, 2024 and 289 on October 1, 2025. Read SEC document |
| December 02, 2021 Filed Apr 28, 2022 17:01 UTC |
Xilas AndrewSVP and GM, Dental
|
Exercise / conversionOrdinary Shares | 333 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-026029 · doc4.xml · nonDerivative · entry 1 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,506 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: 1,156 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 289 on October 3, 2022; 289 on October 2, 2023; 289 on October 1, 2024 and 289 on October 1, 2025. Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 21:33 UTC |
Majors Cary LSr VP N America Com Operations
|
SaleOrdinary Shares | 1,950 | $232.97 | $454,291.50 |
DisclosureSEC source: 0001209191-21-065113 · doc4.xml · nonDerivative · entry 1 Majors Cary L · CIK 0001776271 · Sr VP N America Com Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,697 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $232.95 to $233.02 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · balance_after: 9,767 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,520 on May 31, 2022; 2,224 on May 31, 2023; 2,367 on June 3, 2024; 1,964 on June 2, 2025 and 692 on October 1, 2025. Read SEC document |
| October 22, 2021 Filed Oct 25, 2021 20:32 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $67.98 | $0.00 |
DisclosureSEC source: 0001209191-21-061498 · doc4.xml · derivative · entry 4 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 20,000 shares Expires 2025-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option to purchase 20,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 20,000 Old STERIS ordinary shares for $67.98 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| October 22, 2021 Filed Oct 25, 2021 20:32 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
SaleOrdinary Shares | 20,000 | $235.00 | $4,700,000.00 |
DisclosureSEC source: 0001209191-21-061498 · doc4.xml · nonDerivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,444 F2 · shares: This exercise of stock options and sale of a total of 20,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on June 4, 2021. F1 · balance_after: 12,340 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,240 on May 31, 2022; 2,780 on May 31, 2023; 2,452 on June 3, 2024; 1,719 on June 3, 2024; 432 on October 1, 2024; 573 on June 2, 2025 and 144 on October 1, 2025. Read SEC document |
| October 22, 2021 Filed Oct 25, 2021 20:32 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
Exercise / conversionOrdinary Shares | 20,000 | $67.98 | $1,359,600.00 |
DisclosureSEC source: 0001209191-21-061498 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: 12,340 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,240 on May 31, 2022; 2,780 on May 31, 2023; 2,452 on June 3, 2024; 1,719 on June 3, 2024; 432 on October 1, 2024; 573 on June 2, 2025 and 144 on October 1, 2025. Read SEC document |
| October 11, 2021 Filed Oct 13, 2021 16:31 UTC |
Xilas AndrewSVP and GM, Dental
|
Exercise / conversionRestricted Stock Units · Derivative | 506 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-060362 · doc4.xml · derivative · entry 3 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,713 Underlying: Ordinary Shares · 506 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The STERIS RSUs will vest as follows: 333 on December 2, 2021; 606 on October 7, 2022; 503 on October 10, 2022; 333 on December 2, 2022; 605 on October 7, 2023 and 333 on December 2, 2023. F3 · derivative.exercise_date: The STERIS RSUs will vest as follows: 333 on December 2, 2021; 606 on October 7, 2022; 503 on October 10, 2022; 333 on December 2, 2022; 605 on October 7, 2023 and 333 on December 2, 2023. F3 · derivative.expiration_date: The STERIS RSUs will vest as follows: 333 on December 2, 2021; 606 on October 7, 2022; 503 on October 10, 2022; 333 on December 2, 2022; 605 on October 7, 2023 and 333 on December 2, 2023. Read SEC document |
| October 11, 2021 Filed Oct 13, 2021 16:31 UTC |
Xilas AndrewSVP and GM, Dental
|
Tax withholdingOrdinary Shares | 149 | $221.54 | $33,009.46 |
DisclosureSEC source: 0001209191-21-060362 · doc4.xml · nonDerivative · entry 2 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,173 F2 · shares: Ordinary shares withheld to satisfy taxes. F1 · balance_after: 1,156 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 289 on October 3, 2022; 289 on October 2, 2023; 289 on October 1, 2024 and 289 on October 1, 2025. Read SEC document |
| October 11, 2021 Filed Oct 13, 2021 16:31 UTC |
Xilas AndrewSVP and GM, Dental
|
Exercise / conversionOrdinary Shares | 506 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-060362 · doc4.xml · nonDerivative · entry 1 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,322 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: 1,156 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 289 on October 3, 2022; 289 on October 2, 2023; 289 on October 1, 2024 and 289 on October 1, 2025. Read SEC document |
| October 07, 2021 Filed Oct 12, 2021 16:31 UTC |
Xilas AndrewSVP and GM, Dental
|
Exercise / conversionRestricted Stock Units · Derivative | 607 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-060231 · doc4.xml · derivative · entry 3 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,219 Underlying: Ordinary Shares · 607 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The STERIS RSUs will vest as follows: 506 on October 11, 2021; 333 on December 2, 2021; 606 on October 7, 2022; 503 on October 10, 2022; 333 on December 2, 2022; 605 on October 7, 2023 and 333 on December 2, 2023. F3 · derivative.exercise_date: The STERIS RSUs will vest as follows: 506 on October 11, 2021; 333 on December 2, 2021; 606 on October 7, 2022; 503 on October 10, 2022; 333 on December 2, 2022; 605 on October 7, 2023 and 333 on December 2, 2023. F3 · derivative.expiration_date: The STERIS RSUs will vest as follows: 506 on October 11, 2021; 333 on December 2, 2021; 606 on October 7, 2022; 503 on October 10, 2022; 333 on December 2, 2022; 605 on October 7, 2023 and 333 on December 2, 2023. F4 · balance_after: This balance has been reduced to reflect the correct number of RSUs held following an overstatement of 80 RSUs in the Reporting Person's Form 4 filed June 4, 2021. Read SEC document |
| October 07, 2021 Filed Oct 12, 2021 16:31 UTC |
Xilas AndrewSVP and GM, Dental
|
Tax withholdingOrdinary Shares | 179 | $217.33 | $38,902.07 |
DisclosureSEC source: 0001209191-21-060231 · doc4.xml · nonDerivative · entry 2 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,816 F2 · shares: Ordinary shares withheld to satisfy taxes. F1 · balance_after: 1,156 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 289 on October 3, 2022; 289 on October 2, 2023; 289 on October 1, 2024 and 289 on October 1, 2025. Read SEC document |
| October 07, 2021 Filed Oct 12, 2021 16:31 UTC |
Xilas AndrewSVP and GM, Dental
|
Exercise / conversionOrdinary Shares | 607 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-060231 · doc4.xml · nonDerivative · entry 1 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,995 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: 1,156 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 289 on October 3, 2022; 289 on October 2, 2023; 289 on October 1, 2024 and 289 on October 1, 2025. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 17:03 UTC |
Xilas AndrewSVP and GM, Dental
|
GrantEmployee Stock Options (right to buy) · Derivative | 6,304 | $0.00 Strike: $228.36 | $0.00 |
DisclosureSEC source: 0001209191-21-059547 · doc4.xml · derivative · entry 2 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,304 Underlying: Ordinary Shares · 6,304 shares Expires 2031-10-01 F3 · derivative.exercise_date: This option becomes exercisable as follows: 1,576 on October 3, 2022; 1,576 on October 2, 2023; 1,576 on October 1, 2024 and 1,576 on October 1, 2025. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 17:03 UTC |
Xilas AndrewSVP and GM, Dental
|
GrantOrdinary Shares | 1,156 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059547 · doc4.xml · nonDerivative · entry 1 Xilas Andrew · CIK 0001863490 · SVP and GM, Dental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,388 F1 · shares: All 1,156 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 289 on October 3, 2022; 289 on October 2, 2023; 289 on October 1, 2024 and 289 on October 1, 2025. F2 · balance_after: 1,156 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 289 on October 3, 2022; 289 on October 2, 2023; 289 on October 1, 2024 and 289 on October 1, 2025. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:57 UTC |
Madsen JuliaSenior VP, Life Sciences
|
GrantEmployee Stock Option (right to buy) · Derivative | 3,152 | $0.00 Strike: $228.36 | $0.00 |
DisclosureSEC source: 0001209191-21-059531 · doc4.xml · derivative · entry 3 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,152 Underlying: Ordinary Shares · 3,152 shares Expires 2031-10-01 F4 · derivative.exercise_date: This option becomes exercisable as follows: 788 on October 3, 2022; 788 on October 2, 2023; 788 on October 1, 2024 and 788 on October 1, 2025. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:57 UTC |
Madsen JuliaSenior VP, Life Sciences
|
Disposition to issuerOrdinary Shares | 121 | $228.36 | $27,631.56 |
DisclosureSEC source: 0001209191-21-059531 · doc4.xml · nonDerivative · entry 2 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,312 F3 · shares: 121 shares were withheld from the 349 restricted shares that vested on October 1, 2021. These 121 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 349 restricted shares were part of an award of 1,396 ordinary shares that were awarded to Ms. Madsen on October 1, 2020. These vested shares were valued at the NYSE closing market price on October 1, 2021. F2 · balance_after: 3,737 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 121 on May 31, 2022; 92 on May 31, 2022; 123 on June 1, 2022; 360 on June 2, 2022; 349 on October 3, 2022; 144 on October 3, 2022; 92 on May 31, 2023; 123 on June 1, 2023; 360 on June 2, 2023; 349 on October 2, 2023; 144 on October 2, 2023; 23 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024; 144 on October 1, 2024; 360 on June 2, 2025 and 144 on October 1, 2025. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:57 UTC |
Madsen JuliaSenior VP, Life Sciences
|
GrantOrdinary Shares | 576 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059531 · doc4.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,433 F1 · shares: All 576 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 144 on October 3, 2022; 144 on October 2, 2023; 144 on October 1, 2024 and 144 on October 1, 2025. F2 · balance_after: 3,737 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 121 on May 31, 2022; 92 on May 31, 2022; 123 on June 1, 2022; 360 on June 2, 2022; 349 on October 3, 2022; 144 on October 3, 2022; 92 on May 31, 2023; 123 on June 1, 2023; 360 on June 2, 2023; 349 on October 2, 2023; 144 on October 2, 2023; 23 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024; 144 on October 1, 2024; 360 on June 2, 2025 and 144 on October 1, 2025. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:56 UTC |
Fraser Mary ClareVice President & Chief HRO
|
GrantEmployee Stock Option (right to buy) · Derivative | 3,784 | $0.00 Strike: $228.36 | $0.00 |
DisclosureSEC source: 0001209191-21-059528 · doc4.xml · derivative · entry 2 Fraser Mary Clare · CIK 0001818882 · Vice President & Chief HRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,784 Underlying: Ordinary Shares · 3,784 shares Expires 2031-10-01 F3 · derivative.exercise_date: This option becomes exercisable as follows: 946 on October 3, 2022; 946 on October 2, 2023; 946 on October 1, 2024 and 946 on October 1, 2025. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:56 UTC |
Fraser Mary ClareVice President & Chief HRO
|
GrantOrdinary Shares | 692 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059528 · doc4.xml · nonDerivative · entry 1 Fraser Mary Clare · CIK 0001818882 · Vice President & Chief HRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,458 F1 · shares: All 692 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse on October 1, 2025. F2 · balance_after: 4,901 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 791 on June 1, 2022; 791 on June 1, 2023; 791 on June 1, 2024; 1,836 on June 2, 2025 and 692 on October 1, 2025. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 21:02 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
GrantEmployee Stock Option (rigt to buy) · Derivative | 9,460 | $0.00 Strike: $228.36 | $0.00 |
DisclosureSEC source: 0001209191-21-059542 · doc4.xml · derivative · entry 3 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,460 Underlying: Ordinary Shares · 9,460 shares Expires 2031-10-01 F4 · derivative.exercise_date: This option becomes exercisable as follows: 2,365 on October 3,2022; 2,365 on October 2, 2023; 2,365 on October 1, 2024 and 2,365 on October 1, 2025. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 21:02 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
GrantOrdinary Shares | 576 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059542 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,444 F1 · shares: All 576 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 432 on October 1, 2024 and 144 on October 1, 2025. F2 · balance_after: 12,340 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,240 on May 31, 2022; 2,780 on May 31, 2023; 2,452 on June 3, 2024; 1,719 on June 3, 2024; 432 on October 1, 2024; 573 on June 2, 2025 and 144 on October 1, 2025. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 21:04 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
GrantEmployee Stock Option (right to buy) · Derivative | 8,196 | $0.00 Strike: $228.36 | $0.00 |
DisclosureSEC source: 0001209191-21-059554 · doc4.xml · derivative · entry 2 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,196 Underlying: Ordinary Shares · 8,196 shares Expires 2031-10-01 F3 · derivative.exercise_date: This option becomes exercisable as follows: 2,049 on October 3, 2022; 2,049 on October 2, 2023; 2,049 on October 1, 2024 and 2,049 on October 1, 2025. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 21:04 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
GrantOrdinary Shares | 808 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059554 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,023 F1 · shares: All 808 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 202 on October 3, 2022; 202 on October 2, 2023; 202 on October 1, 2024 and 202 on October 1, 2025. F2 · balance_after: 14,064 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,636 on May 31, 2022; 2,502 on May 31, 2022; 1,504 on June 1, 2022; 819 on June 2, 2022; 202 on October 3, 2022; 834 on May 31, 2023; 752 on June 1, 2023; 819 on June 2, 2023; 202 on October 2, 2023; 752 on June 3, 2024; 819 on June 3, 2024; 202 on October 1, 2024; 819 on June 2, 2025; 202 on October 1, 2025. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 21:00 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
GrantEmployee Stock Options (right to buy) · Derivative | 1,892 | $0.00 Strike: $228.36 | $0.00 |
DisclosureSEC source: 0001209191-21-059539 · doc4.xml · derivative · entry 2 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,892 Underlying: Ordinary Shares · 1,892 shares Expires 2031-10-01 F3 · derivative.exercise_date: This option becomes exercisable as follows: 473 on October 3, 2022; 473 on October 2, 2023; 473 on October 1, 2024 and 473 on October 1, 2025. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 21:00 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
GrantOrdinary Shares | 344 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059539 · doc4.xml · nonDerivative · entry 1 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,716 F1 · shares: All 344 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 258 on October 1, 2024 and 86 on October 1, 2025. F2 · balance_after: 2,544 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 484 on May 31, 2022; 556 on May 31, 2023; 584 on June 3, 2024; 432 on June 3, 2024; 258 on October 1, 2024; 144 on June 2, 2025 and 86 on October 1, 2025. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:59 UTC |
Majors Cary LSr VP N America Com Operations
|
GrantEmployee Stock Option (right to buy) · Derivative | 3,784 | $0.00 Strike: $228.36 | $0.00 |
DisclosureSEC source: 0001209191-21-059536 · doc4.xml · derivative · entry 2 Majors Cary L · CIK 0001776271 · Sr VP N America Com Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,784 Underlying: Ordinary Shares · 3,784 shares Expires 2031-10-01 F3 · derivative.exercise_date: This option becomes exercisable as follows: 946 on October 3, 2022; 946 on October 2, 2023; 946 on October 1, 2024 and 946 on October 1, 2025. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:59 UTC |
Majors Cary LSr VP N America Com Operations
|
GrantOrdinary Shares | 692 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059536 · doc4.xml · nonDerivative · entry 1 Majors Cary L · CIK 0001776271 · Sr VP N America Com Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,647 F1 · shares: All 692 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse on October 1, 2025. F2 · balance_after: 9,767 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,520 on May 31, 2022; 2,224 on May 31, 2023; 2,367 on June 3, 2024; 1,964 on June 2, 2025 and 692 on October 1, 2025. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:50 UTC |
Carestio Daniel ASr VP and Chief Operating Off
|
GrantEmployee Stock Options (right to buy) · Derivative | 18,920 | $0.00 Strike: $228.36 | $0.00 |
DisclosureSEC source: 0001209191-21-059498 · doc4.xml · derivative · entry 2 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,920 Underlying: Ordinary Shares · 18,920 shares Expires 2031-10-01 F3 · derivative.exercise_date: This option becomes exercisable as follows: 4,730 on October 3, 2022; 4,730 on October 2, 2023; 4,730 on October 1, 2024 and 4,730 on October 1, 2025. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:50 UTC |
Carestio Daniel ASr VP and Chief Operating Off
|
GrantOrdinary Shares | 1,156 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059498 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Sr VP and Chief Operating Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,849 F1 · shares: All 1,156 of these ordinary shares are restricted. The restrictions on these shares lapse as follows: 289 on October 3, 2022; 289 on October 2, 2023; 289 on October 1, 2024 and 289 on October 1, 2025. F2 · balance_after: 21,112 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,712 on May 31, 2022; 1,748 on October 3, 2022; 289 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023; 3,028 on June 2, 2023; 289 on October 2, 2023; 1,108 on June 3, 2024; 1,514 on June 3, 2024; 289 on October 1, 2024; 1,514 on June 2, 2025 and 289 on October 1, 2025. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:47 UTC |
Burton Karen LVP, Controller & CAO
|
GrantEmployee Stock Options (right to buy) · Derivative | 1,892 | $0.00 Strike: $228.36 | $0.00 |
DisclosureSEC source: 0001209191-21-059482 · doc4.xml · derivative · entry 2 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,892 Underlying: Ordinary Shares · 1,892 shares Expires 2031-10-01 F3 · derivative.exercise_date: This option becomes exercisable as follows: 473 on October 3, 2022; 473 on October 2, 2023; 473 on October 1, 2024 and 473 on October 1, 2025. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:47 UTC |
Burton Karen LVP, Controller & CAO
|
GrantOrdinary Shares | 344 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059482 · doc4.xml · nonDerivative · entry 1 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,375 F1 · shares: All 344 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 86 on October 3, 2022; 86 on October 2, 2023; 86 on October 1, 2024 and 86 on October 1, 2025. F2 · balance_after: 4,272 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,332 on May 31, 2022; 396 on June 1, 2022; 196 on June 2, 2022; 765 on May 31, 2022; 86 on October 3, 2022; 255 on May 31, 2023; 198 on June 1, 2023; 196 on June 2, 2023; 86 on October 2, 2023; 198 on June 3, 2024; 196 on June 3, 2024; 86 on October 1, 2024; 196 on June 2, 2025 and 86 on October 1, 2025. Read SEC document |
| August 26, 2021 Filed Aug 27, 2021 20:33 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $114.22 | $0.00 |
DisclosureSEC source: 0001209191-21-053628 · doc4.xml · derivative · entry 7 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 436 Underlying: Ordinary Shares · 1,000 shares Expires 2028-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option is part of an option to purchase 2,872 STERIS ordinary shares, of which 1,718 shares are fully vested, which was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 2,872 Old STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| August 26, 2021 Filed Aug 27, 2021 20:33 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 300 | $0.00 Strike: $77.07 | $0.00 |
DisclosureSEC source: 0001209191-21-053628 · doc4.xml · derivative · entry 6 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 300 shares Expires 2027-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is part of an option to purchase 600 STERIS ordinary shares, which are fully vested, which was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 600 Old STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| August 26, 2021 Filed Aug 27, 2021 20:33 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 149 | $0.00 Strike: $69.72 | $0.00 |
DisclosureSEC source: 0001209191-21-053628 · doc4.xml · derivative · entry 5 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 149 shares Expires 2026-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is part of an option to purchase 596 STERIS ordinary shares, which are fully vested, which was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 596 Old STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| August 26, 2021 Filed Aug 27, 2021 20:33 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
SaleOrdinary Shares | 1,449 | $213.63 | $309,549.87 |
DisclosureSEC source: 0001209191-21-053628 · doc4.xml · nonDerivative · entry 4 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,372 F2 · price: Price reflects a weighted average sale price for multiple transactions ranging from $213.5553 to $213.7250 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: 2,200 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 484 on May 31, 2022; 556 on May 31, 2023; 584 on June 3, 2024; 432 on June 3, 2024 and 144 on June 2, 2025. Read SEC document |
| August 26, 2021 Filed Aug 27, 2021 20:33 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
Exercise / conversionOrdinary Shares | 1,000 | $114.22 | $114,220.00 |
DisclosureSEC source: 0001209191-21-053628 · doc4.xml · nonDerivative · entry 3 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,821 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: 2,200 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 484 on May 31, 2022; 556 on May 31, 2023; 584 on June 3, 2024; 432 on June 3, 2024 and 144 on June 2, 2025. Read SEC document |
| August 26, 2021 Filed Aug 27, 2021 20:33 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
Exercise / conversionOrdinary Shares | 300 | $77.07 | $23,121.00 |
DisclosureSEC source: 0001209191-21-053628 · doc4.xml · nonDerivative · entry 2 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,821 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: 2,200 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 484 on May 31, 2022; 556 on May 31, 2023; 584 on June 3, 2024; 432 on June 3, 2024 and 144 on June 2, 2025. Read SEC document |
| August 26, 2021 Filed Aug 27, 2021 20:33 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
Exercise / conversionOrdinary Shares | 149 | $69.72 | $10,388.28 |
DisclosureSEC source: 0001209191-21-053628 · doc4.xml · nonDerivative · entry 1 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,521 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: 2,200 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 484 on May 31, 2022; 556 on May 31, 2023; 584 on June 3, 2024; 432 on June 3, 2024 and 144 on June 2, 2025. Read SEC document |
| August 13, 2021 Filed Aug 17, 2021 20:34 UTC |
Majors Cary LSr VP N America Com Operations
|
GrantEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $114.22 | $0.00 |
DisclosureSEC source: 0001209191-21-051874 · doc4.xml · derivative · entry 5 Majors Cary L · CIK 0001776271 · Sr VP N America Com Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,932 Underlying: Ordinary Shares · 10,000 shares Expires 2028-05-31 F3 · derivative.exercise_date: This option is part of an option to purchase 14,932 STERIS ordinary shares, of which 11,199 are fully vested, and which was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 14,932 Old STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| August 13, 2021 Filed Aug 17, 2021 20:34 UTC |
Majors Cary LSr VP N America Com Operations
|
SaleOrdinary Shares | 299 | $218.64 | $65,373.36 |
DisclosureSEC source: 0001209191-21-051874 · doc4.xml · nonDerivative · entry 4 Majors Cary L · CIK 0001776271 · Sr VP N America Com Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,955 F1 · balance_after: 9,084 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,520 on May 31, 2022; 2,224 on May 31, 2023; 2,376 on June 3, 2024 and 1,964 on June 2, 2025. Read SEC document |
| August 13, 2021 Filed Aug 17, 2021 20:34 UTC |
Majors Cary LSr VP N America Com Operations
|
SaleOrdinary Shares | 701 | $218.62 | $153,252.62 |
DisclosureSEC source: 0001209191-21-051874 · doc4.xml · nonDerivative · entry 3 Majors Cary L · CIK 0001776271 · Sr VP N America Com Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,254 F1 · balance_after: 9,084 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,520 on May 31, 2022; 2,224 on May 31, 2023; 2,376 on June 3, 2024 and 1,964 on June 2, 2025. Read SEC document |
| August 13, 2021 Filed Aug 17, 2021 20:34 UTC |
Majors Cary LSr VP N America Com Operations
|
SaleOrdinary Shares | 10,000 | $218.43 | $2,184,300.00 |
DisclosureSEC source: 0001209191-21-051874 · doc4.xml · nonDerivative · entry 2 Majors Cary L · CIK 0001776271 · Sr VP N America Com Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,955 F2 · price: Price reflects a weighted average sale price for multiple transactions ranging from $218.35 to $218.53 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: 9,084 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,520 on May 31, 2022; 2,224 on May 31, 2023; 2,376 on June 3, 2024 and 1,964 on June 2, 2025. Read SEC document |
| August 13, 2021 Filed Aug 17, 2021 20:34 UTC |
Majors Cary LSr VP N America Com Operations
|
GrantOrdinary Shares | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-051874 · doc4.xml · nonDerivative · entry 1 Majors Cary L · CIK 0001776271 · Sr VP N America Com Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,955 F1 · balance_after: 9,084 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,520 on May 31, 2022; 2,224 on May 31, 2023; 2,376 on June 3, 2024 and 1,964 on June 2, 2025. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 20:41 UTC |
Shah Nirav RDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 2,054 | $0.00 Strike: $217.62 | $0.00 |
DisclosureSEC source: 0001209191-21-051133 · doc4.xml · derivative · entry 3 Shah Nirav R · CIK 0001740213 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,054 Underlying: Ordinary Shares · 2,054 shares Expires 2031-08-10 F2 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 20:41 UTC |
Shah Nirav RDirector
|
Tax withholdingOrdinary Shares | 208 | $217.62 | $45,264.96 |
DisclosureSEC source: 0001209191-21-051133 · doc4.xml · nonDerivative · entry 2 Shah Nirav R · CIK 0001740213 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292 F1 · shares: Ordinary shares withheld to satisfy taxes. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 20:41 UTC |
Shah Nirav RDirector
|
GrantOrdinary Shares | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-051133 · doc4.xml · nonDerivative · entry 1 Shah Nirav R · CIK 0001740213 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 20:39 UTC |
Steeves Richard MartinDirector
|
GrantCareer Restricted Stock Units · Derivative | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-051131 · doc4.xml · derivative · entry 3 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,748 Underlying: Ordinary Shares · 500 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 10, 2021 Filed Aug 12, 2021 20:39 UTC |
Steeves Richard MartinDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 282 | $53.19 Strike: $217.62 | $14,999.58 |
DisclosureSEC source: 0001209191-21-051131 · doc4.xml · derivative · entry 2 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,336 Underlying: Ordinary Shares · 282 shares Expires 2021-08-10 F2 · derivative.exercise_price: These nonqualified stock options were issued to the Reporting Person in lieu of fees of $15,000. F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.